Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Jefferies to Benefit From Increased Investment Banking Momentum, Oppenheimer Says

Jefferies to Benefit From Increased Investment Banking Momentum, Oppenheimer Says

MT newswireMT newswire2026/09/17 21:16
05:16 PM EDT, 09/17/2026 (MT Newswires) -- Jefferies Financial (JEF) is poised to benefit from increased investment banking momentum in the third quarter, Oppenheimer said Thursday. The brokerage raised Jefferies' investment banking outlook to $1.274 billion from $1.059 billion, driven by merger and acquisition and equity underwriting. That pushed Oppenheimer's third-quarter earnings-per-share estimate for Jefferies to $1.06 from $0.67. Five analysts polled by FactSet expect $1 on a GAAP basis. The investment banking and capital markets firm is scheduled to report latest financials on Sept. 28. Jefferies' shares closed 1.1% higher on Thursday, but have fallen nearly 23% this year. JPMorgan Chase (JPM), Morgan Stanley (MS), Goldman Sachs (GS), Bank of America (BAC), Citigroup (C) and Wells Fargo (WFC) all posted strong second-quarter results in July amid trading and investment banking fee gains. Oppenheimer is generally cautious on the large-cap investment banks because their earnings beats have been driven by market trading, rather than a recovery in advisory and corporate deal-making, analysts Chris Kotowski and John Coffey said. Jefferies has derived 58% of its capital markets revenue from investment banking year-to-date, compared with 22% at Goldman, according to the Oppenheimer note. "We still believe in the likelihood of an M&A revival, and think (Jefferies) is exceptionally well positioned to benefit," Kotowski and Coffey wrote. The company's "forward earnings are particularly tied to a sponsor-driven M&A rebound and not so dependent on sustained robust trading activity." Oppenheimer has an outperform rating on Jefferies' stock.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Immunology drug development company Electra (ETRA.US) prices IPO at $15, raising $350 millions, to be listed on Nasdaq tonight

Clinical-stage immunology drug development company Electra Therapeutics Inc. raised $350 million in an upsized U.S. initial public offering (IPO), with the offering price set at the midpoint of the marketed range.

智通财经2026/09/18 07:06

Due to yen weakness and government subsidies, Japan has lowered the price of Tesla (TSLA.US) Model Y to below $23,000.

Tesla’s best-selling electric vehicle model is now being sold at the lowest price globally in Tokyo.

智通财经2026/09/18 06:56

Bridgewater: Most AI infrastructure trades are already priced in, only holding a "very small position"

Bridgewater CIO Greg Jensen warns that assets related to AI infrastructure have already been significantly priced in by the market, and the excess return opportunities of two years ago are fading. The fund has reduced its positions to a "very minimal" level. According to system modeling through 2028, the upside potential for assets such as chips and data centers is now very limited and faces risks of financing and construction delays. Bridgewater's strategic focus has shifted to AI disruption and application sectors.

华尔街见闻2026/09/18 05:56